Amrize Ltd
No SEC Form 4 filings for $AMRZ in the last 30 days.
Amrize Ltd (AMRZ) reported Q2 2026 earnings call highlights citing strong revenue growth and raised guidance. Management said oil-driven cost inflation pressured margins, with adjusted EBITDA up 5.8% but lagging revenue. Cement pricing was slightly down 0.2% YoY in Q2, and full-year adjusted EBITDA guidance was revised to $3.1-$3.2 billion.
Amrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.
Amrize AG shares fell 9.1% to CHF 38.02 after Q2 results missed expectations and the company cut its full-year adjusted EBITDA outlook, citing oil-price driven cost inflation. Q2 EPS was $0.88 vs $0.96 expected, while organic revenue rose 6.7% to $3.5B. Full-year revenue guidance was raised to $12.5B-$12.7B, but adjusted EBITDA was lowered to $3.1B-$3.2B.
Over the past 7 days, alphai's AI scored 5 news stories mentioning AMRZ (Amrize Ltd). Coverage has skewed bullish: 3 bullish, 0 neutral, and 2 bearish.
Recent AMRZ coverage spans earnings, market movers and mergers & acquisitions.
Guidance cut plus margin pressure from cost inflation, partially offset by executed cement price increases and expected second-half pricing momentum.
Amrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.
Guidance cut plus ongoing Building Envelope margin drag is a direct negative catalyst for AMRZ’s near-term valuation and sentiment.
Guidance raise plus explicit oil-price cost headwind and ASPIRE savings outlook should reprice near-term earnings expectations and margin sensitivity.
Q2 beat-style growth plus an FY guidance raise, but earnings headwinds from oil-linked freight, diesel, and raw materials.
alphai scores every news story that mentions AMRZ with an AI model for sentiment and relevance, and aggregates insider trades from Amrize Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Amrize Ltd (AMRZ) reported Q2 2026 earnings call highlights citing strong revenue growth and raised guidance. Management said oil-driven cost inflation pressured margins, with adjusted EBITDA up 5.8% but lagging revenue. Cement pricing was slightly down 0.2% YoY in Q2, and full-year adjusted EBITDA guidance was revised to $3.1-$3.2 billion.
6 min readAmrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.
4 min readAmrize AG shares fell 9.1% to CHF 38.02 after Q2 results missed expectations and the company cut its full-year adjusted EBITDA outlook, citing oil-price driven cost inflation. Q2 EPS was $0.88 vs $0.96 expected, while organic revenue rose 6.7% to $3.5B. Full-year revenue guidance was raised to $12.5B-$12.7B, but adjusted EBITDA was lowered to $3.1B-$3.2B.
4 min readAmrize (AMRZ) reported Q2 2026 revenues of $3,494 million, up 8.6% year over year, with net income rising 14.4% to $476 million and adjusted EBITDA up 5.8% to $986 million. The company returned $502 million via buybacks and dividends and raised FY 2026 guidance, citing demand and oil-price driven cost inflation. Capex was $241 million in the quarter.
6 min readAmrize Ltd (AMRZ) reported Q2 2026 results. Revenues rose 8.6% to $3,494 million, with net income up 14.4% to $476 million and adjusted EBITDA up 5.8% to $986 million. EPS increased 14.7%. The company returned $502 million via buybacks and dividends and updated FY 2026 guidance, citing stronger demand and oil-price driven cost inflation.
6 min readAmrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amrizeq22026pressrelease.htm EX-99.1 amrizeq22026pressrelease Amrize Reports Second Quarter 2026 Results • Revenues up 8.6% with organic growth of 6.7% on strong demand and pricing • Net Income increased 14.4% to $476 million and Adjusted EBITDA grew 5.8% to $986 millio
4 min readAmrize Limited (AMRZ) said it agreed to acquire Rapid Redi-Mix LLC, a Dallas-Fort Worth concrete producer, for undisclosed terms. The company said the deal complements its aggregates and cement operations in Texas and supports recent Midlothian cement expansion and a prior PB Materials acquisition. Amrize shares were up 0.10% at $49.78 on the NYSE.
2 min readInvesting.com reports Amrize AG shares fell 5.8% to $50.87 after Truist Securities analyst Keith Hughes downgraded the stock from Buy to Hold and cut the price target from $65 to $48. The target is below InvestingPro’s fair value ($56.69) and near the 52-week low ($44.12), following Q1 2026 earnings miss and segment volume softness.
3 min readSwiss shares ended flat on Tuesday as gains faded while investors weighed differing accounts of Middle East talks between U.S. President Donald Trump and Israeli PM Benjamin Netanyahu. The SMI finished at 13,305.72 versus 13,305.40. VAT Group (+5%), Logitech (+3.7%) and ABB (+3.21%) rose; Roche and Swiss Re fell 1.4%-2.5%. Switzerland’s trade surplus widened to CHF 3.2bn in April.
4 min readForrest Nollaig (Chief Mktg & Corp Affairs Off) purchased 2,000 shares of Amrize Ltd (AMRZ) at $50.25 ($0.10M total) on 2026-05-22.
2 min read
